US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

Mouse Monoclonal Anti-CD45 Antibody (MEM-28). Tested Applications: Western Blot, Flow Cytometry, ICC, IHC, IHC-Paraffin, IP. Tested Reactivity: Human.

CD45 Antibody (MEM-28) - BSA Free (NB500-319): Novus Biologicals

CD63 Antibody (MX-49.129.5) SCBT - Santa Cruz Biotechnology

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

Discovery of a new class of integrin antibodies for fibrosis

Biotin Rat Anti-Mouse CD49b

The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis

In vivo production of CAR-T cells using CD5/LNP-FAPCAR

CD63 Antibody (MX-49.129.5) SCBT - Santa Cruz Biotechnology

CD95 (FAS) Antibody, anti-human, REAfinity™

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

CD352 (NTB-A) Antibody, anti-human, REAfinity™

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

WO2015183842A1 - Methods and compositions for preventing ischemia

US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5-targeted FAP-CAR T mRNA-LNP - Google Patents